Log In
BCIQ
Print this Print this
 

Pandemic Flu Vaccine with GLA

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionPlant-based virus-like particle (VLP) vaccine against H5N1 avian influenza pandemic with glucopyranosyl lipid A (GLA-AF) adjuvant
Molecular Target Influenza antigen
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationInfluenza virus
Indication DetailsPrevent H5N1 avian influenza virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today